Updated:
DMK PHARMACEUTICALS Corp
DMK PHARMACEUTICALS Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000887247, and its reported...
Overview
DMK PHARMACEUTICALS Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000887247, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-16, it reported annual revenue of USD 4,756,078; net income of USD -26,478,273; total assets of USD 10,930,840 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- DMK PHARMACEUTICALS Corp
- Former names in filing history
- Adamis Pharmaceuticals Corp (2009-04-08 to 2023-09-01); CELLEGY PHARMACEUTICALS INC (1996-07-09 to 2009-04-03)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000887247
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $4.8M | -$26.5M | $10.9M | $1.1M | -$25.9M | |
| FY2021USD | $2.2M | -$45.8M | $38.3M | $23.2M | -$37.8M | |
| FY2020USD | $16.5M | -$49.4M | $30.9M | $6.9M | -$20.9M | |
| FY2019USD | $22.1M | -$29.3M | $47.8M | $8.8M | -$19.9M |
FY2020. Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2019. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research DMK PHARMACEUTICALS Corp in Altss
Track this company’s investors, transactions and relationships in Altss.